THYMIDINE KINASE 2 DEFICIENCY
Clinical trials for THYMIDINE KINASE 2 DEFICIENCY explained in plain language.
Never miss a new study
Get alerted when new THYMIDINE KINASE 2 DEFICIENCY trials appear
Sign up with your email to follow new studies for THYMIDINE KINASE 2 DEFICIENCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental pills target root cause of devastating muscle disease
Disease control OngoingThis study is testing whether two oral supplements (deoxythymidine and deoxycytidine) can help people with a rare genetic disorder called TK2 deficiency. TK2 deficiency causes severe muscle weakness by preventing the body from making enough cellular energy. Researchers hope these…
Matched conditions: THYMIDINE KINASE 2 DEFICIENCY
Phase: PHASE1, PHASE2 • Sponsor: Columbia University • Aim: Disease control
Last updated Mar 25, 2026 14:09 UTC
-
Hope for rare muscle disease: experimental treatment trial advances
Disease control OngoingThis study continues testing an experimental combination therapy (doxecitine and doxribtimine) in people with thymidine kinase 2 deficiency, a rare genetic disorder that causes muscle weakness and breathing problems. The research aims to see if long-term treatment is safe and whe…
Matched conditions: THYMIDINE KINASE 2 DEFICIENCY
Phase: PHASE2 • Sponsor: UCB BIOSCIENCES, Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC